Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, 10(81), p. e203-e203, 2020
DOI: 10.1136/annrheumdis-2020-218788
Links
Tools
Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 